Hiromasa Takaishi

Scopus著者プロファイル

ウェブサイトhttps://k-ris.keio.ac.jp/html/100007146_ja.html

h-index

年別の研究成果

Pureに変更を加えた場合、すぐここに表示されます。

フィンガープリント

Hiromasa Takaishiが活動している研究トピックを掘り下げます。このトピックラベルは、この研究者の研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。

1 類似のプロファイル

85 Article
4 Review article

A significant risk of metabolic dysfunction-associated fatty liver disease plus diabetes on subclinical atherosclerosis
Bessho, R., Kashiwagi, K., Ikura, A., Yamataka, K., Inaishi, J., Takaishi, H. & Kanai, T., 2022 5月, In: PloS one. 17, 5 May, e0269265.
研究成果: Article › 査読

Open Access
10 被引用数 (Scopus)
WJOG13219G: The Efficacy and Safety of FOLFOXIRI or Doublet plus Anti-VEGF Therapy in Previously Untreated BRAF^V600E Mutant Metastatic Colorectal Cancer: A Multi-Institutional Registry-Based Study (BRACELET Study)
Shimozaki, K., Hirata, K., Sato, T., Nakamura, M., Kato, K., Hirano, H., Kumekawa, Y., Hino, K., Kawakami, K., Kito, Y., Matsumoto, T., Kawakami, T., Komoda, M., Nagashima, K., Sato, Y., Yamazaki, K., Hironaka, S., Takaishi, H., Hamamoto, Y. & Muro, K., 2022 12月, In: Clinical Colorectal Cancer. 21, 4, p. 339-346 8 p.
研究成果: Article › 査読

Open Access
A significant association of non-obese non-alcoholic fatty liver disease with osteosarcopenic obesity in females 50 years and older
Kashiwagi, K., Takayama, M., Ichikawa, H., Takaishi, H., Iwao, Y. & Kanai, T., 2021 4月, In: Clinical Nutrition ESPEN. 42, p. 166-172 7 p.
研究成果: Article › 査読
5 被引用数 (Scopus)
Clinical, Endoscopic, and Pathological Characteristics of Immune Checkpoint Inhibitor-Induced Gastroenterocolitis
Hayashi, Y., Hosoe, N., Takabayashi, K., Limpias Kamiya, K. J. L., Tsugaru, K., Shimozaki, K., Hirata, K., Fukuhara, K., Fukuhara, S., Mutaguchi, M., Sujino, T., Sukawa, Y., Hamamoto, Y., Naganuma, M., Takaishi, H., Shimoda, M., Ogata, H. & Kanai, T., 2021 6月, In: Digestive Diseases and Sciences. 66, 6, p. 2129-2134 6 p.
研究成果: Article › 査読

15 被引用数 (Scopus)
Estimating copy number using next-generation sequencing to determine ERBB2 amplification status
Nakamura, K., Aimono, E., Oba, J., Hayashi, H., Tanishima, S., Hayashida, T., Chiyoda, T., Kosaka, T., Hishida, T., Kawakubo, H., Kitago, M., Okabayashi, K., Funakoshi, T., Okita, H., Ikeda, S., Takaishi, H. & Nishihara, H., 2021 4月, In: Medical Oncology. 38, 4, 36.
研究成果: Article › 査読

Open Access
13 被引用数 (Scopus)

高石官均

フィンガープリント

過去5年の共同研究と上位研究分野

詳細を開く

A significant risk of metabolic dysfunction-associated fatty liver disease plus diabetes on subclinical atherosclerosis

WJOG13219G: The Efficacy and Safety of FOLFOXIRI or Doublet plus Anti-VEGF Therapy in Previously Untreated BRAF^V600E Mutant Metastatic Colorectal Cancer: A Multi-Institutional Registry-Based Study (BRACELET Study)

A significant association of non-obese non-alcoholic fatty liver disease with osteosarcopenic obesity in females 50 years and older

Clinical, Endoscopic, and Pathological Characteristics of Immune Checkpoint Inhibitor-Induced Gastroenterocolitis

Estimating copy number using next-generation sequencing to determine ERBB2 amplification status

高石 官均

フィンガープリント

過去5年の共同研究と上位研究分野

研究成果

A significant risk of metabolic dysfunction-associated fatty liver disease plus diabetes on subclinical atherosclerosis

WJOG13219G: The Efficacy and Safety of FOLFOXIRI or Doublet plus Anti-VEGF Therapy in Previously Untreated BRAFV600E Mutant Metastatic Colorectal Cancer: A Multi-Institutional Registry-Based Study (BRACELET Study)

A significant association of non-obese non-alcoholic fatty liver disease with osteosarcopenic obesity in females 50 years and older

Clinical, Endoscopic, and Pathological Characteristics of Immune Checkpoint Inhibitor-Induced Gastroenterocolitis

Estimating copy number using next-generation sequencing to determine ERBB2 amplification status

高石官均

WJOG13219G: The Efficacy and Safety of FOLFOXIRI or Doublet plus Anti-VEGF Therapy in Previously Untreated BRAF^V600E Mutant Metastatic Colorectal Cancer: A Multi-Institutional Registry-Based Study (BRACELET Study)